ES530418A0 - Un procedimiento para la preparacion de pirazolopiridinas. - Google Patents

Un procedimiento para la preparacion de pirazolopiridinas.

Info

Publication number
ES530418A0
ES530418A0 ES530418A ES530418A ES530418A0 ES 530418 A0 ES530418 A0 ES 530418A0 ES 530418 A ES530418 A ES 530418A ES 530418 A ES530418 A ES 530418A ES 530418 A0 ES530418 A0 ES 530418A0
Authority
ES
Spain
Prior art keywords
pirazolopiridinas
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530418A
Other languages
English (en)
Other versions
ES8602783A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838306481A external-priority patent/GB8306481D0/en
Priority claimed from GB838328942A external-priority patent/GB8328942D0/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES530418A0 publication Critical patent/ES530418A0/es
Publication of ES8602783A1 publication Critical patent/ES8602783A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
ES530418A 1983-03-09 1984-03-08 Un procedimiento para la preparacion de pirazolopiridinas. Expired ES8602783A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838306481A GB8306481D0 (en) 1983-03-09 1983-03-09 Compounds
GB838328942A GB8328942D0 (en) 1983-10-29 1983-10-29 Compounds

Publications (2)

Publication Number Publication Date
ES530418A0 true ES530418A0 (es) 1985-12-01
ES8602783A1 ES8602783A1 (es) 1985-12-01

Family

ID=26285454

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530418A Expired ES8602783A1 (es) 1983-03-09 1984-03-08 Un procedimiento para la preparacion de pirazolopiridinas.

Country Status (7)

Country Link
US (1) US4559348A (es)
EP (1) EP0119774B1 (es)
AU (1) AU563920B2 (es)
DE (1) DE3464368D1 (es)
ES (1) ES8602783A1 (es)
GR (1) GR81926B (es)
NZ (1) NZ207410A (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151962A3 (en) * 1984-01-25 1985-10-02 Beecham Group Plc Pyrazolopyridine derivatives
GB8404584D0 (en) * 1984-02-22 1984-03-28 Beecham Group Plc Compounds
EP0193329A3 (en) * 1985-02-22 1987-08-19 Beecham Group Plc Pyrazolopyridines, their preparation and pharmaceutical compositions containing them
AT382377B (de) * 1985-04-27 1987-02-25 Beecham Group Plc Verfahren zur herstellung von neuen 7-substituierten aminopyrazolo(4,3-b)pyridinen
GB8600752D0 (en) * 1986-01-14 1986-02-19 Roussel Lab Ltd Chemical compounds
EP0239191A3 (en) * 1986-01-30 1988-07-20 Beecham Group Plc Pyrazolo[4,3-b]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
GB8609421D0 (en) * 1986-04-17 1986-05-21 Beecham Group Plc Compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7459562B2 (en) 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
TW200538453A (en) 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US20050288290A1 (en) 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7432373B2 (en) 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
WO2007035428A1 (en) 2005-09-15 2007-03-29 Bristol-Myers Squibb Company Met kinase inhibitors
US7547782B2 (en) 2005-09-30 2009-06-16 Bristol-Myers Squibb Company Met kinase inhibitors
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Also Published As

Publication number Publication date
AU563920B2 (en) 1987-07-30
EP0119774B1 (en) 1987-06-24
US4559348A (en) 1985-12-17
ES8602783A1 (es) 1985-12-01
DE3464368D1 (de) 1987-07-30
NZ207410A (en) 1987-04-30
AU2535484A (en) 1984-09-13
EP0119774A1 (en) 1984-09-26
GR81926B (es) 1984-12-12

Similar Documents

Publication Publication Date Title
ES539625A0 (es) Un procedimiento para la preparacion de derivados de fenetano.
ES533753A0 (es) Un procedimiento para la preparacion de nuevas fenoxialquil-1-2-4-triazolonas.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES533285A0 (es) Un procedimiento para la preparacion de nuevos oligopeptidos.
ES536590A0 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
ES533738A0 (es) Un procedimiento para la preparacion de ditiofosfatos metalicos.
ES534892A0 (es) Un procedimiento para la preparacion de derivados de penem-2-metil sustituidos.
ES536525A0 (es) Un procedimiento para la preparacion de derivados de fenotiazinas.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES535953A0 (es) Un procedimiento para la preparacion de derivados 3-cefem-4-carboxilicos.
ES530418A0 (es) Un procedimiento para la preparacion de pirazolopiridinas.
ES538907A0 (es) Un procedimiento para la preparacion de derivados enol-eteres de oxicanis.
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES529846A0 (es) Un procedimiento para la preparacion de derivados benzoheterociclicos.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES509312A0 (es) Un procedimiento para la preparacion de 1-3-hidroxi-4-metoxibenzoil-3-hidroxi-2-pirrolidinona.
ES531792A0 (es) Un procedimiento para la preparacion de un compuesto.
ES509432A0 (es) Un procedimiento para la preparacion de arilaminas.
ES533389A0 (es) Un procedimiento para la preparacion de nuevos derivados de tiosulfonamida.
ES529213A0 (es) Un procedimiento para la preparacion de derivados de isoquinuclidina.
ES534642A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbaciclina.
ES530973A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES543776A0 (es) Un procedimiento para la preparacion de nuevos 16-fluor-16, 17-dideshidro prostanoides
ES534269A0 (es) Un procedimiento para la preparacion de nuevos derivados de difeniletanona.
ES528986A0 (es) Un procedimiento para la preparacion de un compuesto de beta-lactama.